Stockscreener 앱 받기
4.47
4.08%
-0.19
시장 영업 전:
4.43
-0.04
-0.89%
Lexeo Therapeutics Inc 주식(LXEO)의 최신 뉴스
Lexeo Therapeutics Inc (LXEO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Lexeo Therapeutics Inc (LXEO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Lexeo Therapeutics Inc (LXEO) Balance Sheet - TradingKey
Lexeo Therapeutics Inc (LXEO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lexeo Therapeutics Inc (LXEO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Lexeo Therapeutics Inc (LXEO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Lexeo Therapeutics Inc (LXEO) Cash Flow - TradingKey
TradingKey - TradingKey
LXEO|Lexeo Therapeutics Inc|Price:4.660|Chg%:-0.050 - TradingKey
Lexeo Therapeutics Inc (LXEO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Lexeo Therapeutics Inc (LXEO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Lexeo Therapeutics Inc (LXEO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Lexeo’s SUNRISE-FA 2 Trial Puts Gene Therapy for Rare Heart Disease in Investor Focus - TipRanks
Lexeo Therapeutics (LXEO) Faces Continued Selling Pressure as Shares Test Key Support LevelsSuperTrend Flip - dars.gov.et
What Makes Lexeo Therapeutics (LXEO) One of The Best Stocks Under $10 That Could Triple - Yahoo Finance
Lexeo Therapeutics (LXEO) Slips 4.55% as Stock Tests Support Near $4.58Channel Projection - dars.gov.et
LXEO News | LEXEO THERAPEUTICS INC (NASDAQ:LXEO) - ChartMill
Lexeo Therapeutics (LXEO) Slips 4.55% as Stock Tests Proximity to Key SupportZero Lag EMA - dars.gov.et
Lexeo Therapeutics Slips 5.3% as Biotech Volatility Weighs on LXEO SharesVolatility Surface - dars.gov.et
Lexeo Therapeutics (LXEO) Edges Higher as Key Support HoldsPassive Flow - dars.gov.et
Have Lexeo Therapeutics Insiders Been Selling Stock? - 富途牛牛
Stifel Maintains Lexeo Therapeutics(LXEO.US) With Buy Rating, Maintains Target Price $17 - Moomoo
LXEOLexeo Therapeutics Inc Dividends - Finviz
Have Insiders Sold Lexeo Therapeutics Shares Recently? - simplywall.st
Is Lexeo Therapeutics, Inc. (LXEO) Stock Still a Gene Therapy Opportunity After Analyst Valuation Update? - Yahoo Finance
Lexeo Therapeutics CMO sells $98,592 in shares By Investing.com - Investing.com South Africa
Lexeo Therapeutics CMO sells $98,592 in shares - Investing.com
Lexeo Therapeutics COO Otero sells $20,903 in LXEO stock By Investing.com - Investing.com Australia
Lexeo Therapeutics COO Otero sells $20,903 in LXEO stock - Investing.com
Form 4 Lexeo Therapeutics Inc For: 1 July By Investing.com - Investing.com India
RSU grant and tax-cover share sale by Lexeo (LXEO) chief financial officer - Stock Titan
Lexeo Therapeutics (LXEO) COO reports stock award and small tax-related sale - Stock Titan
Lexeo Therapeutics (LXEO) CMO awarded 55K shares and sells 22K to cover RSU taxes - Stock Titan
Lexeo Therapeutics (LXEO) CEO logs RSU grant and tax-driven share sale - Stock Titan
Form 144 Lexeo Therapeutics For: 1 July By Investing.com - Investing.com UK
LXEO (NASDAQ) Form 144: Proposed resale of 4,666 vested shares via Fidelity - Stock Titan
Form 144 Lexeo Therapeutics For: 1 July - Investing.com India
[144] Lexeo Therapeutics, Inc. SEC Filing - Stock Titan
LXEO (NASDAQ: LXEO) director files Form 144 proposing sale of 25,947 shares - Stock Titan
5 Best Up and Coming Pharmaceutical Stocks to Buy Now - Insider Monkey
Form 4 Lexeo Therapeutics Inc For: 29 June By Investing.com - Investing.com South Africa
Lexeo Shareholders Reelect Directors, Ratify KPMG Auditor - TipRanks
Lexeo Therapeutics (NASDAQ: LXEO) investors approve directors and ratify KPMG auditor - Stock Titan
Lexeo Therapeutics (LXEO) director awarded options on 35,000 shares at $4.70 - Stock Titan
Lexeo Therapeutics (LXEO) director receives 35,000 options at $4.70 - Stock Titan
Lexeo Therapeutics (LXEO) director awarded 35,000 stock options at $4.70 - Stock Titan
Lexeo Therapeutics (LXEO) director awarded 35,000 stock options at $4.70 strike - Stock Titan
Lexeo Therapeutics (LXEO) director receives grant of 35,000 stock options at $4.70 - Stock Titan
Lexeo Therapeutics, Inc. Actuals & Estimates (NASDAQ:LXEO) - TradingView
LXEO Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of Lexeo Therapeutics, Inc. – NASDAQ:LXEO - TradingView
Price to book forward of Lexeo Therapeutics, Inc. – NASDAQ:LXEO - TradingView
Enterprise value to revenue forward of Lexeo Therapeutics, Inc. – NASDAQ:LXEO - TradingView
Price to earnings forward of Lexeo Therapeutics, Inc. – NASDAQ:LXEO - TradingView
LEXEO THERAPEUTICS INC (LXEO) Stock Chart - ChartMill
1.97%
0.83%
자본화:
|
볼륨(24시간):